GS-P-C vs XENE
Comparison between Goldman Sachs Group Inc (GS-P-C, Company) and Xenon Pharmaceuticals Inc (XENE, Company).
5-Year PerformanceXENE has outperformed GS-P-C, delivering a return of +27.7% compared to +0.6%
GS-P-C vs XENE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
GS-P-C
$5.83B
XENE
$5.83B
Max Drawdown
Winner
GS-P-C
32.55%
XENE
90.43%
Sharpe Ratio
GS-P-C
-0.94
Winner
XENE
1.19
5Y Beta
Winner
GS-P-C
0.19
XENE
0.93
Industry
GS-P-C
N/A
XENE
Biotechnology
P/E Ratio
GS-P-C
0.35
Winner
XENE
-12.96
PEG Ratio
GS-P-C
0.01
Winner
XENE
-0.32
5Y Dividends CAGR
GS-P-C
9.67%
XENE
N/A
5Y EPS CAGR
GS-P-C
15.67%
Winner
XENE
40.27%
Debt to Equity
GS-P-C
0.00%
XENE
0.00%
Free Cash Flow Yield
GS-P-C
N/A
XENE
-5.27%
P/S Ratio
GS-P-C
N/A
XENE
727.44
P/B Ratio
GS-P-C
N/A
XENE
4.36
GS-P-C vs XENE - Historical Returns
Returns include dividend reinvestment.
1M
GS-P-C
-1.38%
Winner
XENE
+23.75%
3M
GS-P-C
+0.16%
Winner
XENE
+9.92%
6M
GS-P-C
-2.26%
Winner
XENE
+50.45%
1Y
GS-P-C
-4.56%
Winner
XENE
+99.09%
5Y(CAGR)
GS-P-C
+0.62%
Winner
XENE
+27.73%
10Y(CAGR)
GS-P-C
+4.28%
Winner
XENE
+24.65%
Max(CAGR)
GS-P-C
+4.64%
Winner
XENE
+16.66%
GS-P-C vs XENE - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | GS-P-C | XENE |
|---|---|---|
| 2026 | -1.00% | +42.44% |
| 2025 | -11.84% | +11.58% |
| 2024 | +17.40% | -12.71% |
| 2023 | +21.38% | +23.62% |
| 2022 | -18.32% | +24.82% |
| 2021 | +6.34% | +111.94% |
| 2020 | +13.51% | +12.10% |
| 2019 | +28.11% | +96.26% |
| 2018 | -14.85% | +119.48% |
| 2017 | +8.95% | -64.01% |
| 2016 | +8.92% | -3.27% |
| 2015 | +10.60% | -57.01% |
| 2014 | -2.34% | +88.10% |
GS-P-C vs XENE Drawdown Comparison
The maximum drawdown for GS-P-C was -31.19%, occurring on Mar 23, 2020. Recovery took 129 trading sessions.
The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.
The current GS-P-C drawdown is -15.22%.
| Rank | GS-P-C | XENE |
|---|---|---|
| #1 | -31.19% Feb 14, 2020 - Aug 19, 2020 | -90.43% Jan 8, 2015 - Oct 4, 2021 |
| #2 | -29.85% Sep 4, 2018 - Jan 3, 2020 | -43.59% Feb 9, 2024 - Mar 9, 2026 |
| #3 | -25.52% Nov 3, 2021 - Jan 26, 2024 | -34.08% May 9, 2023 - Dec 22, 2023 |
| #4 | -17.25% Feb 25, 2025 - Mar 31, 2026 | -30.14% Nov 5, 2021 - Aug 4, 2022 |
| #5 | -12.14% Oct 10, 2016 - May 4, 2017 | -25.87% Nov 11, 2014 - Dec 11, 2014 |
| #6 | -7.55% Apr 23, 2015 - Oct 28, 2015 | -18.40% Mar 9, 2026 - Jul 7, 2026 |
| #7 | -7.39% Nov 11, 2015 - Apr 21, 2016 | -17.08% Mar 1, 2023 - May 3, 2023 |
| #8 | -7.07% Oct 27, 2017 - Mar 16, 2018 | -16.98% Aug 24, 2022 - Feb 13, 2023 |
| #9 | -5.61% Jun 26, 2024 - Oct 17, 2024 | -11.44% Oct 15, 2021 - Nov 2, 2021 |
| #10 | -5.56% Sep 17, 2020 - Oct 6, 2020 | -11.09% Dec 11, 2014 - Dec 29, 2014 |
| #11 | -4.98% Dec 11, 2024 - Feb 25, 2025 | -9.36% Feb 13, 2023 - Mar 1, 2023 |
| #12 | -4.97% Sep 22, 2014 - Feb 9, 2015 | -8.58% Jan 8, 2024 - Feb 8, 2024 |
| #13 | -4.26% Jan 29, 2021 - Apr 5, 2021 | -8.27% Aug 10, 2022 - Aug 24, 2022 |
| #14 | -4.00% Mar 16, 2018 - Jun 15, 2018 | -6.08% Dec 29, 2014 - Jan 7, 2015 |
| #15 | -3.78% Oct 31, 2024 - Nov 29, 2024 | -4.89% Dec 27, 2023 - Jan 8, 2024 |
Correlation
Correlation between GS-P-C and XENE is 0.74 which considered as a strong positive correlation - the stocks tend to move together.
0.74
-101
Select Stocks to Compare
Popular: GS-P-C vs SPYXENE vs SPY
More Comparisons
Compare with similar stocks